Children's Allegra Allergy patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8933097 CHATTEM SANOFI Fexofenadine suspension formulation
Aug, 2030

(6 years from now)

Children'S Allegra Allergy is owned by Chattem Sanofi.

Children'S Allegra Allergy contains Fexofenadine Hydrochloride.

Children'S Allegra Allergy has a total of 1 drug patent out of which 0 drug patents have expired.

Children'S Allegra Allergy was authorised for market use on 24 January, 2011.

Children'S Allegra Allergy is available in suspension;oral dosage forms.

The generics of Children'S Allegra Allergy are possible to be released after 02 August, 2030.

Drugs and Companies using FEXOFENADINE HYDROCHLORIDE ingredient

Market Authorisation Date: 24 January, 2011

Treatment: NA


How can I launch a generic of CHILDREN'S ALLEGRA ALLERGY before it's drug patent expiration?
More Information on Dosage


Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic